Taylor Wessing advises Bayer Healthcare AG in a divestment of animal health biological vaccines to Intervet

16-Feb-2006  |  Corporate, Intellectual Property, Life Sciences & Healthcare, Technology

CLIENT

Bayer Healthcare AG

VALUE

Not disclosed

TRANSACTION

M & A

DESCRIPTION

Advised Bayer Healthcare AG on the divestment of the production of animal health biological vaccines to Intervet, a subsidiary of Akzo Nobel